Α-Galactosidases is developed by our company based on advanced microbial breeding and fermentation techniques, and takes into account the intestinal characteristics of animals and the anti-nutritional characteristics of feeds, the refined enzyme products are produced by submerged fermentation and advanced ...
3, and/or; iii) encodes a polypeptide being at least 50 % identical with the polypeptide having the amino acid sequence shown in the appended SEQ ID No. 3, as well as an 伪-galactosidase enzyme encoded by the DNA construct.doi:EP0692024 B1KNAP Inge Helmer...
whose content ratio is highest in beans seed while lowest in grain seed. Poultry has no endogenous enzyme to digest α-galactosidase but pigs can partially ferment it with the aid of intestinal microorganism,yielding CO2 and NH3 at the same time, which arouses flatulence, nausea, ...
(al'fă gă-lak'tō-sī'dās) An enzyme catalyzing the hydrolysis of α-d-galactosides to release freed-galactose. A deficiency of type A α-d-galactosidase is associated with Fabry disease. Medical Dictionary for the Health Professions and Nursing © Farlex 2012 ...
a sphingolipidosis transmitted as an X-linked recessive trait, in which the glycolipid trihexosyl ceramide is deposited in various tissues, especially the kidneys; the deficient enzyme is α-galactosidase A. It is marked by purpuric skin lesions (angiokeratomas), central nervous system symptoms, ...
(2005). The effect of α-galactosidase enzyme with and without Avizyme 1502 on performance of broilers fed diets based on corn and soybean meal. Int. J.Poul.Res., 4, 920-937.The effect of alpha-galactosidase enzyme with and without Avizyme 1502 on performance of broilers fed diets based...
α-Galactosidase, (E.C. 3.2.1.22) is anexoglycosidasethat targetgalactooligosaccharidessuch asraffinose,melibiose,stachyoseand branchedpolysaccharideslikegalactomannansand galacto-glucomannans by catalysing thehydrolysisof α-1,6 linked terminalgalactoseresidues. Theenzymehas been isolated and characterized from...
Enzyme replacement therapy (ERT) with GLA is currently the most effective therapeutic strategy for patients with Fabry disease, a lysosomal storage disease. 实验方案 Product Specific Protocols WB protocol for Alpha Galactosidase A antibody 66121-1-Ig Download protocol IHC protocol for Alpha Galactosidase...
Thus, even though the active enzyme from all three species has almost an equal molecular weight, structural resemblances, as well as dissimilarities, are probable. Description melA E. coli Recombinant produced in E. coli is a single polypeptide chain containing 474 amino acids (1-451) and ...
A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. 仅用于科研。不用于诊断过程。未经明确授权不得转售。